Literature DB >> 21807923

New fecal occult blood tests may improve adherence and mortality rates.

Veena Kumaravel1, Stephen P Hayden, Geraldine S Hall, Carol A Burke.   

Abstract

Several new fecal occult blood tests have advantages over older ones when used for colorectal cancer screening. Fecal immunochemical tests can detect antibodies to human globin in the stool and can be used without the dietary restrictions needed with traditional guaiac tests. Although colonoscopy is often considered the gold standard, we hope that these new tests will allow more people to be screened and more cases of colorectal cancer to be detected early.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807923     DOI: 10.3949/ccjm.78a.11024

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  4 in total

1.  Diagnostic utility of immunochemical fecal occult blood tests to detect lower gastrointestinal lesions in patients with chronic kidney disease.

Authors:  Yoo A Choi; Sang Hoon Yoo; Youn Mi Song; Se Young Kim; Yunju Nam; Sooa Choi; Bong Han Kong; Hye Eun Yoon; Yu Ah Hong; Yoon Kyung Chang; Chul Woo Yang; Suk Young Kim; Hyeon Seok Hwang
Journal:  Int J Colorectal Dis       Date:  2015-04-14       Impact factor: 2.571

2.  Prevalence of intestinal parasites among children referred to Children's Medical Center during 18 years (1991-2008), Tehran, Iran.

Authors:  M T H Ashtiani; M Monajemzadeh; B Saghi; S Shams; S H Mortazavi; S Khaki; N Mohseni; L Kashi; B Nikmanesh
Journal:  Ann Trop Med Parasitol       Date:  2011-10

Review 3.  Detection of miRNA as non-invasive biomarkers of colorectal cancer.

Authors:  Albert Ren; Yujuan Dong; Ho Tsoi; Jun Yu
Journal:  Int J Mol Sci       Date:  2015-01-27       Impact factor: 5.923

4.  Diagnostic Value of Combining miRNAs, CEA Measurement and the FOBT in Colorectal Cancer Screening.

Authors:  Xiaodan Li; Rong Chen; Zhifa Li; Bing Luo; Wenyan Geng; Xiaobing Wu
Journal:  Cancer Manag Res       Date:  2020-04-15       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.